Yan Wu
Yan Wu is principal scientist at Merck & Co., Inc.
Articles
Risk-Based Predictive Stability for Pharmaceutical Development–A Proposed Regulatory Template
Jin Wang;Fenghe Qiu;Megan McMahon;Elke Debie;Helen Williams;Dennis Stephens;Cherokee Hoaglund Hyzer;Yan Wu;Hanlin Li
August 2nd 2018A published regulatory template sharing best practices for filing RBPS data would benefit the industry and regulatory reviewers by enabling a consistent presentation of predictive data and conclusions.
Latest Updated Articles
Published: October 11th 2024 | Updated: October 18th 2024
Buy, Sell, Hold: Cell and Gene Therapy - Part 1
Published: September 10th 2024 | Updated: September 18th 2024
CPHI Milan Announces 2024 CPHI Pharma Award Finalists
Published: February 23rd 2024 | Updated: December 22nd 2024
Europa Perspectives: Helping to Navigate the Regulatory System
Published: December 13th 2024 | Updated: December 22nd 2024
FDA Creates CDER Center for Real-World Evidence Innovation
Published: December 5th 2024 | Updated: December 22nd 2024
Leveraging Advancements in Bioanalytical Testing
Published: December 7th 2024 | Updated: December 22nd 2024
Exploring Opportunities for LNP Delivery in mRNA
